According to a recent study, a new biomarker may make it possible to make a prognosis regarding the progression of the autoimmune disease rheumatoid arthritis (RA).
The results of the study, which was carried out at the University of Munich Clinics, were recently published in the Annals of the Rheumatic Diseases, The EULAR Journal. At the centre of this study lies an analysis of the cell hormone interleukin-22, IL-22, and its significance as a prognostic marker for RA. The researchers examined the relationship between the serum levels of interleukin-22 and the risk of bone erosion and joint damage in RA patients. Continue reading
Filed under: autoimmunity, Research Update, rheumatism, rheumatoid arthritis (RA), rheumatology diagnostics | Tagged: autoimmune diagnostics, autoimmunity, RA, rheumatism, rheumatoid arthritis (RA) | Leave a comment »